Pages that link to "Q36294809"
Jump to navigation
Jump to search
The following pages link to Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length. (Q36294809):
Displaying 50 items.
- Focus on Adoptive T Cell Transfer Trials in Melanoma (Q21328679) (← links)
- A transposon and transposase system for human application (Q24630047) (← links)
- T cell replicative senescence in human aging (Q27022690) (← links)
- Advances in the treatment of metastatic melanoma: adoptive T-cell therapy (Q27027803) (← links)
- High-content molecular profiling of T-cell therapy in oncology (Q28066792) (← links)
- Sleeping beauty system to redirect T-cell specificity for human applications (Q30535187) (← links)
- IFN-γ Upregulates Survivin and Ifi202 Expression to Induce Survival and Proliferation of Tumor-Specific T Cells (Q33761188) (← links)
- Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts (Q33772479) (← links)
- RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth (Q34044752) (← links)
- Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma (Q34111789) (← links)
- Telomerase and Primary T Cells: Biology and Immortalization for Adoptive Immunotherapy (Q34170012) (← links)
- Th17 cells are long lived and retain a stem cell-like molecular signature (Q34241261) (← links)
- Predicting cytotoxic T-cell age from multivariate analysis of static and dynamic biomarkers (Q34616800) (← links)
- Immunotherapy for ovarian cancer: what's next? (Q34743514) (← links)
- Telomeres and aging (Q34768068) (← links)
- Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy (Q34823783) (← links)
- CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer (Q34905454) (← links)
- Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy (Q35115741) (← links)
- Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence (Q35720116) (← links)
- Improving TCR Gene Therapy for Treatment of Haematological Malignancies (Q35738738) (← links)
- T cell immune reconstitution following lymphodepletion. (Q36334023) (← links)
- IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy (Q36677310) (← links)
- Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA. (Q36882726) (← links)
- Genetic modification of T cells for immunotherapy (Q36909362) (← links)
- GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development (Q36960744) (← links)
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. (Q37117781) (← links)
- Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients (Q37129671) (← links)
- Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry (Q37363693) (← links)
- Novel therapeutics for the treatment of metastatic melanoma (Q37486788) (← links)
- Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion (Q37677403) (← links)
- White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy (Q37843043) (← links)
- Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses (Q37963294) (← links)
- Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells (Q38170500) (← links)
- Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development (Q38217028) (← links)
- A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy (Q38227889) (← links)
- Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes (Q38266264) (← links)
- Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A review (Q38544057) (← links)
- Predictors of tumor-infiltrating lymphocyte efficacy in melanoma (Q38665128) (← links)
- Adoptive Cellular Therapy (ACT) for Cancer Treatment (Q38848219) (← links)
- Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells. (Q38849182) (← links)
- Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment (Q39503772) (← links)
- CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting. (Q42136462) (← links)
- CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers (Q42181212) (← links)
- Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death (Q42381105) (← links)
- Promoting thiol expression increases the durability of antitumor T-cell functions (Q42549343) (← links)
- N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of Foxo1 in an Akt-dependent manner. (Q48112031) (← links)
- Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution. (Q50554742) (← links)
- Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion (Q50973652) (← links)
- Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity (Q58883571) (← links)
- IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype (Q82287260) (← links)